Literature DB >> 33561854

Reflux Symptoms: Functional and Structural Diseases and the Approach from the GI Specialist.

Lars Lundell1,2.   

Abstract

The GI specialist has an important role to play in the long-term management of gastroesophageal reflux disease (GERD) patients to secure a proper diagnosis and the selection of best possible therapeutic strategy. Through intensified information and education, the implementation of national and international guidelines can be more effectively processed, whereupon a significant improvement in cost-effectiveness of the current management will be fostered. Regarding the more specific group of GERD patients, as represented by the so-called PPI-refractory patients, data have now emerged to guide us into the future. Noteworthy is that the majority of the alleged PPI-refractory GERD patients do not, after careful investigations, have GERD. Based on recently published RCT data, a clinically highly relevant difference in treatment success was noted in favor of laparoscopic antireflux surgery as compared to a variety of medical treatment alternatives. Likewise, it can be concluded that it seems as if the latter can only offer a limited effect. Whenever a corresponding powerful clinical difference in therapeutic outcome between different strategies and treatment alternatives is detected, this will have a huge impact on treatment algorithms and clinical management.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  24-h pH-metry; Antireflux surgery; Endoscopy; Gastroesophageal reflux disease; Impedance; Proton pump inhibitor; Specialists

Mesh:

Substances:

Year:  2021        PMID: 33561854      PMCID: PMC8686707          DOI: 10.1159/000515109

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  31 in total

1.  Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.

Authors:  Anna Niklasson; Lina Lindström; Magnus Simrén; Greger Lindberg; Einar Björnsson
Journal:  Am J Gastroenterol       Date:  2010-03-23       Impact factor: 10.864

2.  Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.

Authors:  Stuart J Spechler; John G Hunter; Karen M Jones; Robert Lee; Brian R Smith; Hiroshi Mashimo; Vivian M Sanchez; Kerry B Dunbar; Thai H Pham; Uma K Murthy; Taewan Kim; Christian S Jackson; Jason M Wallen; Erik C von Rosenvinge; Jonathan P Pearl; Loren Laine; Anthony W Kim; Andrew M Kaz; Roger P Tatum; Ziad F Gellad; Sandhya Lagoo-Deenadayalan; Joel H Rubenstein; Amir A Ghaferi; Wai-Kit Lo; Ronald S Fernando; Bobby S Chan; Shirley C Paski; Dawn Provenzale; Donald O Castell; David Lieberman; Rhonda F Souza; William D Chey; Stuart R Warren; Anne Davis-Karim; Shelby D Melton; Robert M Genta; Tracey Serpi; Kousick Biswas; Grant D Huang
Journal:  N Engl J Med       Date:  2019-10-17       Impact factor: 91.245

Review 3.  Management of refractory typical GERD symptoms.

Authors:  Emidio Scarpellini; Daphne Ang; Ans Pauwels; Adriano De Santis; Tim Vanuytsel; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

4.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

5.  Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.

Authors:  Jean-Paul Galmiche; Jan Hatlebakk; Stephen Attwood; Christian Ell; Roberto Fiocca; Stefan Eklund; Göran Långström; Tore Lind; Lars Lundell
Journal:  JAMA       Date:  2011-05-18       Impact factor: 56.272

6.  The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria.

Authors:  Prateek Sharma; John Dent; David Armstrong; Jacques J G H M Bergman; Liebwin Gossner; Yoshio Hoshihara; Janusz A Jankowski; Ola Junghard; Lars Lundell; Guido N J Tytgat; Michael Vieth
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

Review 7.  Functional esophageal disorders.

Authors:  Jean Paul Galmiche; Ray E Clouse; András Bálint; Ian J Cook; Peter J Kahrilas; William G Paterson; Andre J P M Smout
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 8.  Evidence-based appraisal of antireflux fundoplication.

Authors:  Marco Catarci; Paolo Gentileschi; Claudio Papi; Alessandro Carrara; Renato Marrese; Achille Lucio Gaspari; Giovanni Battista Grassi
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

Review 9.  Proton pump inhibitors: use and misuse in the clinical setting.

Authors:  Vincenzo Savarino; Elisa Marabotto; Patrizia Zentilin; Manuele Furnari; Giorgia Bodini; Costanza De Maria; Gaia Pellegatta; Claudia Coppo; Edoardo Savarino
Journal:  Expert Rev Clin Pharmacol       Date:  2018-10-10       Impact factor: 5.045

10.  Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.

Authors:  Janusz A Z Jankowski; John de Caestecker; Sharon B Love; Gavin Reilly; Peter Watson; Scott Sanders; Yeng Ang; Danielle Morris; Pradeep Bhandari; Claire Brooks; Stephen Attwood; Rebecca Harrison; Hugh Barr; Paul Moayyedi
Journal:  Lancet       Date:  2018-07-26       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.